Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | MCP-1 (MCAF) | 22.0 | 9 | ||||||||
0 | MCP-1 (MCAF) | 12.0 | 9 | ||||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MCP-1 (MCAF) | 55.0 | 27 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | MCP-1 (MCAF) | 78.0 | 27 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MCP-1 (MCAF) | 81.0 | 25 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | MCP-1 (MCAF) | 83.5 | 34 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | MCP-1 (MCAF) | 76.5 | 42 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | MCP-1 (MCAF) | 135.0 | 30 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 4 | MCP-1 (MCAF) | 134.0 | 28 | ||||
RA2159 | 4 | MCP-1 (MCAF) | 174.0 | 19 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 4 | MCP-1 (MCAF) | 127.0 | 15 | ||||
N2645 | 4 | MCP-1 (MCAF) | 280.0 | 23 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 4 | MCP-1 (MCAF) | 222.5 | 22 | ||||
RA2708 | 4 | MCP-1 (MCAF) | 256.5 | 20 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 119.0 | 28 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 1348.0 | 33 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 129.0 | 38 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 225.0 | 24 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 185.5 | 24 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 883.0 | 35 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 4502.0 | 21 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 5849.0 | 27 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 1906.0 | 27 | |
N2645 | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 3828.0 | 24 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | MCP-1 (MCAF) | 5613.0 | 25 |